There is an unmet need for treatment of erectile dysfunction resulting from radical prostatectomy and cavernous nerve (CN) injury. Given the neuroprotective properties of docosahexaenoic acid (DHA), we investigated its effect on penile functional and structural recovery in a rat model of bilateral cavernous nerve injury. Rats were subject to CN injury and received intraperitoneal administration of either vehicle or a DHA nanoemulsion (nano-DHA) at 10, 50, or 250 μg/kg. Functional testing and histological analyses were performed at 28 days post-injury. The maximum intracavernosal pressure (ICP) and other measures of erectile function were significantly higher in the nano-DHA groups than in the vehicle group (p < 0.05). The ratio of area of expression of neuronal nitric oxide synthase (nNOS)/β-III tubulin, numbers of axon and smooth muscle cell content were significantly higher in the 50 μg/kg nano-DHA group than in the vehicle group (p < 0.05). A qualitative increase in the smooth muscle cells/ collagen ratio and decrease in apoptosis was observed in the nano-DHA groups relative to the vehicle group: however, these differences were not statistically significant. Our data demonstrate that nano-DHA, particularly the 50 μg/kg regimen, improves erectile function after bilateral CN injury in rats by neuroprotection and other anti-fibrotic and anti-apoptotic mechanisms.
Radical prostatectomy is the first-line therapy for prostate cancer. Despite the introduction of improved surgical techniques and nerve-sparing procedures, erectile dysfunction observed after radical prostatectomy due to neuropraxia of the cavernous nerves (CNs) is common. According to recent estimates, normal erectile function following nerve-sparing radical prostatectomy is only 20-25%, and these rates have not improved over the last 17 years 1 . A majority of men lose erectile function for up to 3 months after surgery. Recovery often requires a minimum of 2 years, and full recovery of normal function is rare. Several therapeutic approaches including rehabilitation with PDE5 inhibitors, immunomodulation, neurotrophic factor administration, and regenerative techniques (e.g., stem cell therapy) either have failed to translate to clinical use or have not been studied in humans due to various concerns, such as use in cancer patients and unfavourable pharmacokinetics 2 . Polyunsaturated fatty acids (PUFAs) are constituents of the cell membrane and the primary structural components of the brain, skin, sperm, testicles, and retina. In vivo and in vitro studies have characterized the neuroprotective effects of omega-3 PUFAs, particularly docosahexaenoic acid (DHA) [3] [4] [5] [6] . Paterniti et al. demonstrated in a model of spinal cord injury that DHA treatment mediates an anti-inflammatory effect, attenuates the expression . It is well known that apoptosis, loss of smooth muscle cells, fibrosis, and abnormal neuronal nitric oxide synthase (nNOS) activity occur in response to CN injury 8 . Additionally, it has been suggested that PUFAs are capable of altering penile morphological features including the density of smooth muscle cells and collagen fibers 9 , which are often implicated in cavernous nerve injury. Therefore, DHA can be considered a candidate therapy for the treatment of erectile dysfunction following CN injury. However, the administration of DHA in high concentrations results in a loss of its beneficial actions 10 and produces toxicity at concentrations > 100 μ g/mL 11 . Therefore, studies are required to characterize the therapeutic utility and associated therapeutic index of DHA for the treatment of erectile dysfunction due to CN injury. Here, we aimed to characterize the effect and appropriate dosage of nanoemulsion (nano)-DHA in a rat model of bilateral CN injury and erectile dysfunction. Specifically, we investigated the effect of 3 regimens of nano-DHA (10 μ g/kg, 50 μ g/kg, and 250 μ g/kg) on functional and structural changes in the corpus cavernosum (CC) and CNs.
Results
Nano-DHA restores erectile function. The effects of nano-DHA treatment on recovery of erectile function are illustrated in Fig. 1 . It shows the intracavernosal pressure (ICP) and arterial blood pressure (BP) in the sham, vehicle, and nano-DHA-treated (10 μ g/kg, 50 μ g/kg, and 250 μ g/kg, respectively) groups at 28 days post-injury. The maximum ICP of nano-DHA groups (10 μ g/kg, 67.93 ± 20.72; 50 μ g/kg, 94.05 ± 12.22; 250 μ g/kg, 73.64 ± 10.08) and the sham group (105.92 ± 17.29) were significantly higher than those of the vehicle group (40.63 ± 9.87) (p < 0.05 for all comparisons). The area under the curve (AUC) for ICP and ∆ ICP/MAP measures and the maximum ICP/MAP values were significantly higher for all nano-DHA groups (except the 10 μ g/kg group) and the sham group than those for the vehicle group (p < 0.05 for all comparisons). Of note, the maximum ICP of the 50 μ g/kg nano-DHA group was higher than that of the 10 μ g/kg nano-DHA group (Table 1) .
Nano-DHA enhance the nNOS-positive fibers in the cavernous nerve and the dorsal penile nerve.
The nNOS-positive fibers of the CN and dorsal penile nerve (DPN) were immunostained for β -III-tubulin to identify nerve fibers positive for nNOS and to quantify their nNOS content (representative images of each group in Fig. 2a,b) . The result shows that the number of nNOS-positive nerve fibres in the CN and DPN was increased in the nano-DHA-treated group relative to the vehicle-treated group. The ratio of the area of expression of nNOS/β -III tubulin was significantly higher in the 50 μ g/kg nano-DHA group and the sham group than in the vehicle group (p < 0.05 for both comparisons) (Fig. 2c) .
Nano-DHA restores the axonal contents of the dorsal penile nerve. The axon contents of the dorsal penile nerve were assessed for neurofilament-1 (NF-1) expression by immunofluorescence staining. Representative images of each group were shown in Fig. 3a . There was a significant reduction in NF-1 expression in the dorsal penile nerve in the vehicle only group compared with the 50 μ g/kg nano-DHA group and sham group (p < 0.05; Fig. 3b ). In additional, no significant correlation was uncovered between NF-1 expression and functional result.
Nano-DHA decreases iNOS production in the dorsal penile nerve. We performed immunofluorescence staining to evaluate the expression of iNOS in the dorsal penile nerve and artery bundle of penile tissue (Fig. 4) . The result showed an increase in iNOS expression in both dorsal nerve bundle and the dorsal artery of CN injury rat compared with that in sham group, whereas iNOS expression in the dorsal penile nerve bundle were decreased in 50 μ g/kg nano-DHA treatment group. However, there was no difference in the expression of iNOS of dorsal artery among all treated and vehicle only groups.
Nano-DHA increases smooth muscle cell content and attenuates collagen deposition in the corpus cavernosum. Smooth muscle actin (α -SMA) was significantly higher in the 50 μ g/kg nano-DHA group and the sham group than in the vehicle group (p < 0.05 for both comparisons). Masson's Trichrome staining in the area of the CC lesion exhibited reduced collagen in the nano-DHA groups and the sham group relative to the vehicle only group (Fig. 5 ). The ratio of the area of expression of smooth muscle cells and collagen was higher in all nano-DHA groups and the sham group than in the vehicle group, signifying reduced fibrosis after treatment with nano-DHA; however, this difference was only statistically significant for the sham group (p < 0.05).
Nano-DHA rescues cell damage in the corpus cavernosum. Figure 6 depicts an increase in apoptotic cells in the CC positive for both transferase-mediated dUTP-biotin nick end labelling (TUNEL) and 40,6-diamidino-2-phenylindole (DAPI) after CN nerve crush. In nano-DHA groups, the proportion of apoptotic cells per unit was lower but statistically insignificant from the vehicle group, whereas the sham group exhibited a significantly lower proportion of apoptotic cells per unit relative to the vehicle group (p < 0.05).
Discussion
Despite the common use of radical prostatectomy for the treatment of prostate cancer, the preservation of penile erectile function remains a challenge due to mechanical damage to the CN. In the present study, we found that treatment with nano-DHA resulted in the recovery of erectile function as defined by increases in ICP, MAP, and other functional measures. The functional status in terms of maximum ICP/MAP following CN injury was 35% at 28 days post-injury in the vehicle group, which is consistent with previous studies in this model 8, 12 .
The maximum ICP/MAP was increased to 64% following injury in the 50 μ g/kg nano-DHA group. Indeed, the therapeutic effect of nano-DHA was most prominent in the 50 μ g/kg group (maximum ICP, 94.05 ± 12.22 cmH 2 O vs. 40.63 ± 9.87 cmH 2 O in the vehicle group; maximum ICP/MAP, 0.64 ± 0.18 vs. 0.35 ± 0.10 in the vehicle group). These data indicate that nano-DHA has therapeutic utility for promoting the functional recovery of erectile function following mechanical damage to the CN.
We examined whether functional recovery was accompanied by the improvement of neurological and histological markers of injury in our study. Both smooth muscle cell actin and collagen play an important role in fibroblast contractility 13 . The ratio of smooth muscle cells to collagen content is progressively reduced following CN injury or resection, indicating the increasing severity of fibrosis post-injury 8 . Indeed, bilateral CN ablation has been reported to induce fibrosis by reducing the number of smooth muscle cells and increasing collagen synthesis 14 . In the present study, we observed a decrease in the ratio of smooth muscle actin to collagen following CN injury, but only qualitative attenuation of this ratio after treatment with nano-DHA. It is possible that our results did not reach statistical significance due to the natural trend of increasing fibrosis after CN injury. A longer follow-up period may be required to observe statistically significant improvements in fibrosis. Nevertheless, these findings are consistent with the known anti-fibrotic properties of nutritional DHA 15 and the attenuation of profibrotic factors such as transforming growth factor beta (TGFβ ) and connective tissue growth factor (CTFG) following injury 16, 17 . Reductions of nNOS and nitric oxide (NO) required to sustain penile erection and increased apoptosis of penile smooth muscle cells are also implicated in erectile dysfunction following CN injury 18, 19 . DHA is an important mediator of NOS activity and is able to modulate lipid peroxidation and protein oxidation to inhibit apoptosis 3, 6, [20] [21] [22] . Here, we showed that nano-DHA increased the expression of nNOS and β -III tubulin in the DPN and CN, indicative of nerve repair. iNOS is shown to modulate critical features of inflammation, neovascularization, and collagen deposition on the fibrovascular tissue induced by sponge implants in mice 23 [42] . It has been also demonstrated to be upregulated with age in rat penis in association with ED 24 [17] . Our results revealed that CN injury induces inflammation by increased the expression of iNOS in the dorsal penile nerve and artery. Nano-DHA treatment attenuates the expression of iNOS in dorsal penile nerve when compared with untreated injured rat. We clearly demonstrated that treatment with DHA could increase the rate of regeneration of axon and preservation of nNOS-positive nerve fibers by reducing the inflammatory response after nerve injury.
Furthermore, nano-DHA qualitatively decreased damage to the CC, as exhibited by the preservation of corporal smooth muscle cell and an apparent but not statistically significant decrease in the proportion of apoptotic cells following CN injury. Of note, while the TUNEL assay is highly sensitive, it has poor precision in detecting the magnitude of broken DNA strands, and does not adequately distinguish between cells undergoing apoptosis and cells in the processes of DNA repair 25 . We believe that this may explain the lack of statistically significant observations regarding apoptosis after nano-DHA administration in our study. The ability to protect neurons against cell death is critical to functional recovery following traumatic neuronal injury. Our findings provide evidence that nano-DHA has utility for penile rehabilitation via the regeneration of nNOS-containing nerves, increase of the axonal contents, reducing of neural inflammation and the reversal of smooth muscle cell apoptosis. Indeed, it has been reported that DHA may promote penile rehabilitation by stimulating neurite growth and synaptogenesis via the inhibition of nitric oxide production and the enhancement of glutamatergic transmission 11, 25, 26 . DHA is a key component of neuronal membranes at sites of signal transduction, and is reduced following neuronal injury 27 . DHA treatment following various types of injuries such as traumatic brain injury 27 , spinal cord injury 3, 5, 6 , and ischemic stroke 28 has led to neural recovery by reducing oxidative stress and attenuating inflammatory responses. There is evidence that DHA exerts its antioxidant and anti-inflammatory effect by suppressing pro-inflammatory cytokines such as tumour necrosis factor-α (TNF-α ), decreasing nitrite levels, and promoting glutathione (GSH) and antioxidant enzyme activities. In conclusion, nano-DHA (particularly the 50 μ g/kg regimen) restored erectile function in a rat model of erectile dysfunction due to bilateral CN injury, and functional improvement was accompanied by structural recovery of the penile tissue. The underlying mechanism of nano-DHA in restoration of erectile function is neuroprotection and further contributed to anti-fibrotic and anti-apoptotic of corpus cavernosum. While additional studies are required to verify our findings, the documented safety and tolerability of DHA makes it an excellent candidate for clinical use in the treatment of erectile dysfunction following radical prostatectomy.
Methods
Animals and experimental design. Forty Sprague Dawley rats (12 weeks, 400-450 g) were obtained from Bioasco Taiwan (Taipei, Taiwan), housed in a controlled environment, and provided a standard diet ad libitum. Rats were randomly and equally divided into 5 groups (each group n = 8). CN injury or sham surgery was performed at the initiation of the study. Functional testing and histological analyses were performed in sham and CN injury groups at 28 days post-injury. After the functional evaluation, various tissues including the MPG, CN, CC, and DPN were collected for histological evaluation. All the animal experiment methods were conducted in accordance with the guidelines and regulation established by The Fu Jen Catholic University, Taiwan. All the experimental protocols in the present study were approved by The Fu Jen Catholic University Animal Care and Use Committee, Taiwan.
Preparation of DHA nanoemulsion. The DHA nanoemulsion was prepared by combining 40 mg of oil containing 38 mg DHA/g with 1.2 g of Tween 80 and homogenizing with a glass rod. The homogenate was then Surgical procedures. Rats were anesthetized with 50 mg/kg pentobarbital sodium and the abdomen was shaved and disinfected with an iodine-based solution. A lower midline abdominal incision was made and the prostate gland was exposed. The posterolateral CNs and MPG were identified bilaterally. At this point in the sham group, there was no further surgical manipulation. In the 4 CN injury groups, the CNs were isolated and a crushing injury was applied using a haemostat clamp (Roboz Surgical Instrument Co., Inc., Gaithersburg, MD, USA) for 2 min. Lastly, the 4 CN injury groups were administered vehicle (saline), 10 μ g/Kg nano-DHA, 50 μ g/Kg nano-DHA, or 250 μ g/Kg nano-DHA intraperitoneally and the abdomen was closed in 2 layers.
Measurement of erectile response. Erectile response was surgically assessed in all rats 4 weeks after sham or CN injury surgery and nano-DHA or vehicle injection. Rats were prepared for surgery as previously described and the abdomen was opened through a repeat midline abdominal incision. The CNs were exposed and isolated, and the crus of the penis was identified. A 24-gauge needle containing 50 U/mL heparin solution was inserted into the right penile crus and connected to a polyethylene-50 tube to measure intracavernosal pressure (ICP) with an MP36 pressure transducer (Biopac Systems Inc., CA, USA) and BSL 3.7.3 software (Biopac Systems). CNs were stimulated using a bipolar stainless steel electrode. Monophasic rectangular pulses were generated by a computer with a DS3 constant-current isolated stimulator (AutoMate Scientific Inc., CA, USA). The stimulus parameters were as follows: amplitude, 1.5 mA; frequency, 20 Hz; pulse duration, 0.2 ms; and total duration, 60 s. Erectile tissue response was determined in real time and measured by the maximal ICP, change in ICP (Δ ICP), area under the ICP curve, and ratio of change in ICP and mean arterial pressure (MAP; Δ ICP/MAP). The ICP operator was blinded to the treatment groups.
Immunofluorescence staining. All animals were sacrificed by administration of a high dose of pentobarbital sodium solution. Tissue from the middle portion of the penis was collected from each of the 36 rats, fixed with formalin for 24 h (10% formaldehyde w/v), and subsequently dehydrated, post-fixed, and embedded in paraffin. Cross-sections of the embedded penile tissue were cut into 5-μ m-thick slices, fixed, and deparaffinized in xylene for 10 min. The procedure was repeated twice for a total of 3 treatments and followed by hydration in graded alcohols. Slides were incubated for 1 h in 10% goat serum/2% bovine serum albumin/0.2% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) at room temperature. The tissues were subsequently removed from the solutions and incubated overnight at 4 °C with the following primary antibodies: rabbit anti-neural nitric oxide synthase (nNOS; Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-neuron-specific β -III tubulin, mouse anti-α -smooth muscle actin (Abcam Inc., Cambridge, MA, USA), rabbit anti-iNOS (Calbiochem, La Jolla, CA, USA) and mouse anti-neurofilament (NF-1) (Santa Cruz Biotechnology, Santa Cruz, California, USA). After incubation, the tissues were incubated with a 1:400 dilution of secondary antibody conjugated to Alexa Fluor 488 Figure 6 . Transferase-mediated dUTP-biotin nick end labelling staining co-localization with nuclear 40,6-diamidino-2-phenylindole (DAPI) staining, original magnifications x100 and x400. Cells positive for both transferase-mediated dUTP-biotin nick end labelling and DAPI were considered to be apoptotic. Apoptosis was increased in the rat corpus cavernosum after cavernous nerve crush without. *p < 0.05 versus the vehicle group.
or Texas Red (Invitrogen, Carlsbad, CA, USA) for 1 h. Slides were then evaluated by fluorescence microscopy. For further analysis of nNOS and smooth muscle cell content, the ratio of the area of nNOS-positive cells to the area of β -III tubulin-positive cells in nerve fibres and the α -smooth muscle actin area of the CC were calculated at 400x and 100x magnifications, respectively. All computerized histomorphometric analyses were performed using ImageJ (National Institutes of Health, Bethesda, MD, USA).
Masson's Trichrome Staining. Penile tissue sections were fixed with 10% buffered formalin and stained using the Masson trichrome staining reagent kit according to the manufacturer's instructions (Muto Pure Chemicals, Tokyo, Japan). All computerized histomorphometric analyses of the CC were performed using Olympus cellSens software (Olympus LATIN AMERICA, INC., Miami, FL, USA).
Transferase-mediated dUTP-biotin nick end labelling (TUNEL) staining. The quantification of apoptotic cells was performed by detecting DNA damage in-situ with the Apo-BrdU In Situ DNA Fragmentation Assay Kit (BioVision, Inc., CA, USA) and counterstaining with 4′ ,6-diamidino-2-phenylindole (DAPI) in paraffin-embedded tissue sections. The apoptotic index was expressed as the number of TUNEL and DAPI-positive cells in 6 randomly chosen high-power fields (× 400) of the sinusoids in corpus cavernosum per rat, which were photographed and digitally analyzed.
Statistical Analysis. The overall data were summarized using descriptive statistics and expressed as the mean ± standard deviation. Comparison of multiple treatment groups was performed with a 1-way analysis of variance and pairwise post hoc comparisons with the Scheffe test. All statistical analyses were performed using SPSS Version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows and p < 0.05 was considered to be statistically significant.
